Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
BMC Immunology
|
June 16, 2018
Cancer immunoprevention: from mice to early clinical trials
Arianna Palladini, Lorena Landuzzi, Pier-Luigi Lollini, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 16, 2020
Ewing Sarcoma PDX Models
Didier Surdez, Lorena Landuzzi, Katia Scotlandi, et al.
International Journal of Molecular Sciences
|
February 26, 2025
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches
Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, et al.
Cancers
|
February 11, 2023
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, et al.
Cells
|
March 6, 2021
Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
Lorena Landuzzi, Maria Cristina Manara, Pier-Luigi Lollini, et al.
Future Oncology (London, England)
|
November 12, 2009
Molecular and cellular biology of rhabdomyosarcoma
Carla De Giovanni, Lorena Landuzzi, Giordano Nicoletti, et al.
The Breast Journal
|
November 6, 2010
Immunoprevention and immunotherapy of mammary carcinoma
Pier-Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, et al.
Cancers
|
August 12, 2023
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
Lorena Landuzzi, Maria Cristina Manara, Laura Pazzaglia, et al.
European Journal of Cell Biology
|
October 27, 2007
RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells
Svenja Ehlers, Tobias Mueck, Stephanie Adams, et al.
Cells
|
August 7, 2021
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
Carla De Giovanni, Lorena Landuzzi, Arianna Palladini, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
BMC Immunology
|
June 16, 2018
Cancer immunoprevention: from mice to early clinical trials
Arianna Palladini, Lorena Landuzzi, Pier-Luigi Lollini, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 16, 2020
Ewing Sarcoma PDX Models
Didier Surdez, Lorena Landuzzi, Katia Scotlandi, et al.
International Journal of Molecular Sciences
|
February 26, 2025
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches
Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, et al.
Cancers
|
February 11, 2023
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, et al.
Cells
|
March 6, 2021
Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
Lorena Landuzzi, Maria Cristina Manara, Pier-Luigi Lollini, et al.
Future Oncology (London, England)
|
November 12, 2009
Molecular and cellular biology of rhabdomyosarcoma
Carla De Giovanni, Lorena Landuzzi, Giordano Nicoletti, et al.
The Breast Journal
|
November 6, 2010
Immunoprevention and immunotherapy of mammary carcinoma
Pier-Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, et al.
Cancers
|
August 12, 2023
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
Lorena Landuzzi, Maria Cristina Manara, Laura Pazzaglia, et al.
European Journal of Cell Biology
|
October 27, 2007
RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells
Svenja Ehlers, Tobias Mueck, Stephanie Adams, et al.
Cells
|
August 7, 2021
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
Carla De Giovanni, Lorena Landuzzi, Arianna Palladini, et al.
Page
of 9